Patent details

EP2928473 Title: REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES

Basic Information

Publication number:
EP2928473
PCT Application Number:
US2013072710
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138613914
PCT Publication Number:
WO2014088983
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES
French Title of Invention:
ARYLATION N-2 RÉGIOSÉLECTIVE D'INDAZOLES
German Title of Invention:
REGIOSELEKTIVE N-2-ARYLIERUNG VON INDAZOLEN
SPC Number:

Dates

Filing date:
03/12/2013
Grant date:
28/06/2017
EP Publication Date:
14/10/2015
PCT Publication Date:
12/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/06/2017
EP B1 Publication Date:
28/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/12/2017
Expiration date:
03/12/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/06/2017
 
 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:
HUMPHREY, Guy, R.
Address:
United States (US)

2

Name:
SCOTT, Mark, E.
Address:
United States (US)

3

Name:
CHUNG, Cheol, K.
Address:
United States (US)

4

Name:
BULGER, Paul Gerard
Address:
United States (US)

5

Name:
BELYK, Kevin Michael
Address:
United States (US)

6

Name:
LIMANTO, John
Address:
United States (US)

Priority

Priority Number:
201261734392 P
Priority Date:
07/12/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07D 401/10;

Publication

European Patent Bulletin

Issue number:
201726
Publication date:
28/06/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/04/2018 Outgoing Correspondence 1